...
首页> 外文期刊>BMC Medical Genetics >Two different pathogenic gene mutations coexisted in the same hereditary spherocytosis family manifested with heterogeneous phenotypes
【24h】

Two different pathogenic gene mutations coexisted in the same hereditary spherocytosis family manifested with heterogeneous phenotypes

机译:同一遗传性球形细胞增多症家族中共存在两种不同的致病基因突变,表现为异质表型

获取原文
           

摘要

Hereditary spherocytosis (HS) is a common type of hereditary hemolytic anemia. According to the current diagnostic criteria of HS, patients with a family history of HS, typical clinical features and laboratory investigations could be diagnosed without the requirement of any additional tests, including genetic analysis. However, the clinical heterogeneities incur difficulties in HS diagnosis. We therefore aimed to investigate the application of genetic diagnosis in a family-based cohort. In the present Chinese family, two probands sharing similar clinical manifestations, including jaundice, cholelithiasis, splenomegaly and spherocytes, while the clinical features of other family members were inconclusive. Whole-exome sequencing (WES) unexpectedly unveiled two separate disease-causing mutations in the two probands. SPTB R1625X mutation detected in proband D was a de novo mutation; while proband W inherited the SLC4A1 c.G1469A mutation from her mother, which was also inherited by her brother. However, the clinical features of proband W and her mother and brother were discrepant: proband W suffered from significant splenomegaly, jaundice and cholelithiasis, which resulted in cholecystectomy and splenectomy; while her mother and brother’s HS were not complicated by cholelithiasis, and their splenomegaly and elevated serum bilirubin were moderate. In addition, additional genomic defects involved with HS-related symptoms have not been detected in this family. Both genotypes and phenotypes could be heterogeneous in the same HS family. The analysis of pathogenic gene mutations may endeavor to play an indispensable role in the accurate diagnosis and genetic consultation of HS individuals and their family members.
机译:遗传性球血细胞增多症(HS)是遗传性溶血性贫血的一种常见类型。根据目前的HS诊断标准,可以诊断出具有HS家族史,典型临床特征和实验室检查的患者,而无需任何其他测试,包括基因分析。但是,临床异质性在HS诊断中带来困难。因此,我们旨在研究基因诊断在基于家庭的队列中的应用。在目前的中国家庭中,两个先证者具有相似的临床表现,包括黄疸,胆石症,脾肿大和球细胞,而其他家庭成员的临床特征尚无定论。全外显子测序(WES)意外地在两个先证者中揭示了两个单独的致病突变。先证者D中检测到的SPTB R1625X突变是从头突变;先证者W从她的母亲那里继承了SLC4A1 c.G1469A突变,该突变也由她的兄弟继承。然而,先证者W和她的母亲和兄弟的临床特征是不同的:先证者W患有明显的脾肿大,黄疸和胆石症,导致胆囊切除术和脾切除术;她的母亲和兄弟的HS并没有胆石症,并发脾肿和血清胆红素升高。另外,在该家族中还没有发现与HS相关症状有关的其他基因组缺陷。基因型和表型在同一个HS家族中可能是异质的。致病基因突变的分析可能会在HS个体及其家庭成员的准确诊断和遗传咨询中发挥不可或缺的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号